Table 1.

Baseline Characteristics

	VNS (n=53)	Control (n=55)
Gender (N, %)
Male	34 (64%)	36 (65.5%)
Female	19 (37%)	19 (35%)
Ethnicity (N, %)
Caucasian	42 (79%)	43 (78%)
African-American	9 (17%)	9 (16%)
Asian, Indian, Other	1 (2%)	4 (7%)
Not Reported	1 (2%)	1 (2%)
Age (years, Mean ± SD)	59.1 ± 10.2	61.1 ± 9.2
Time since stroke (years.)	3.1 ± 2.3	3.3 ± 2.6
Handedness (Right/Left/Ambidextrous)	48 (91%) / 4 (8%) / 1 (2%)	50 (91%) / 5 (9) / 0
Side of Paresis (Right/Left)	25 (47%) / 28 (53%)	26 (47%) / 29 (53%)
FMA-UE Baseline Score (Mean ± SD)	34.4 ± 8.2	35.7 ± 7.8
WMFT Functional Score	2.71 ± 0.70	2.83 ± 0.65

Baseline demographic and clinical characteristics by randomisation group in the intention to treat population. FMA-UE is Fugl-Meyer Assessment Upper Extremity. WMFT is Wolf Motor Function Test. Participants could select more than one option for ethnicity.